Picture of IND Swift Laboratories logo

INDSWFTLAB IND Swift Laboratories Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Annual cashflow statement for IND Swift Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1981801251,1321,952
Depreciation
Non-Cash Items860921946754715
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-310-624-879-513-5,012
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,2521,3491,5031,946-1,813
Capital Expenditures-112-44-184-128-445
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items20.7-57.8232-5.98-598
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-91-10247.7-134-1,043
Financing Cash Flow Items-675-839-1,049-1,2858,092
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,333-1,237-1,409-1,8576,989
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-19410.2142-44.14,133